|
Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer molecularly targeted therapy consortium cohort study
|
February 22, 2025
|
PC3I Authors Emily Ko |
Gynecologic Oncology
|
|
Impact of telehealth legislation on gynecologic oncology services: Policy updates
|
February 14, 2025
|
PC3I Authors Lakeisha Mulugeta-Gordon; Emily Gleason; Anna Jo Smith; Emily Ko |
Gynecologic Oncology
|
|
Rideshare services for transportation assistance in gynecologic oncology: a quality improvement study
|
February 14, 2025
|
PC3I Authors Anna Jo Smith; Meredith Doherty; Justin Bekelman; Emily Ko |
BMC Health Services Research
|
|
Racial disparities in receipt of radiation and brachytherapy in cervical cancer patients: Do they exist in a SEER-Medicare population?
|
October 8, 2024
|
PC3I Authors Emily Gleason; Emily Ko |
Gynecologic oncology reports
|
|
Early-career and fellow gynecologic oncologists perceive underpreparedness for the business of medicine: A Society of gynecologic oncology survey study
|
September 21, 2024
|
PC3I Authors Emily Ko |
Gynecologic Oncology Reports
|
|
Current diagnostic guidelines and perpetuation of inequities in ovarian cancer: A National Cancer Database study.
|
May 29, 2024
|
PC3I Authors Anna Jo Smith; Emily Gleason; Anne Marie McCarthy |
Journal of Clinical Oncology
|
|
Role of systematic lymphadenectomy at the time of interval debulking surgery for patients with advanced-stage epithelial ovarian carcinoma who achieved complete gross resection
|
May 16, 2024
|
PC3I Authors Emily Ko |
International Journal of Gynecological Cancer
|
|
“Having cancer is very expensive”: A qualitative study of patients with ovarian cancer and PARP inhibitor treatment
|
May 1, 2024
|
PC3I Authors Anna Jo Smith; Emily Ko; Katharine Rendle |
Gynecologic Oncology
|
|
Addressing transportation barriers in oncology: existing programs and new solutions
|
April 29, 2024
|
PC3I Authors Emily Ko; Meredith Doherty; Anna Jo Smith |
Supportive Care in Cancer
|
|
Ovarian Cancer Isn’t Just a White Woman’s Disease
|
April 4, 2024
|
PC3I Authors Anna Jo Smith; Emily Ko |
JAMA Oncology
|
|
An SGO commentary: U.S. News and World Report gynecologic oncology procedural ratings-Do they reflect high-quality care?
|
March 16, 2024
|
PC3I Authors Emily Ko |
Gynecologic Oncology
|
|
Prior authorization for FDA-approved PARP inhibitors in ovarian cancer
|
February 23, 2024
|
PC3I Authors Anna Jo Smith; Emily Ko |
Gynecologic Oncology Reports
|
|
Financial toxicity in gynecologic oncology: a multi-practice survey
|
February 12, 2024
|
PC3I Authors Anna Jo Smith; Meredith Doherty; Emily Ko |
International Journal of Gynecological Cancer
|
|
Variation in telemedicine usage in gynecologic cancer: Are we widening or narrowing disparities?
|
February 6, 2024
|
PC3I Authors Anna Jo Smith; Emily Ko |
Gynecologic Oncology
|
|
Federal Transportation Regulations Limit Access to Clinical Trials and Oncology Care
|
February 1, 2024
|
PC3I Authors Anna Jo Smith; Emily Ko |
JAMA Oncology
|
|
Treatment of node-positive endometrial cancer: chemotherapy, radiation, immunotherapy, and targeted therapy
|
January 25, 2024
|
PC3I Authors Emily Ko |
Current Treatment Options in Oncology
|
|
Impact of delayed interval cytoreductive surgery on the survival of patients with advanced stage high-grade epithelial ovarian carcinoma
|
December 13, 2023
|
PC3I Authors Emily Ko |
International Journal of Gynecological Cancer
|
|
Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directions
|
November 29, 2023
|
PC3I Authors Emily Ko |
Gynecologic Oncology
|
|
Transportation assistance in gynecologic oncology: A pilot study.
|
October 26, 2023
|
PC3I Authors Anna Jo Smith; Emily Ko; Justin Bekelman |
JCO Oncology Practice
|
|
Impact of adjuvant chemotherapy on the overall survival of patients with advanced-stage low-grade serous ovarian carcinoma following primary cytoreductive surgery
|
October 25, 2023
|
PC3I Authors Emily Ko |
International Journal of Gynecological Cancer
|
